Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
Decision snapshot: SWK stock price vs TECH: inconclusive Relative valuation is incomplete for this pair. Review the available filing metrics before drawing a conclusion.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at TECH's multiple
Needs Annual EPS, TECH P/E.
Implied fair value · at SWK's multiple
Needs Annual EPS, SWK P/E.
Price unavailable
Metric by metric
Where each company leads, and how wide the gap is.
Higher is better
Reported gross margin
Operating income + D&A
Lower is better
Not comparable
Lower leverage
Statements
Annual statements in reported currencies, with calculations and source evidence.
Values retain reported currencies and share bases. Select a figure to inspect its period, calculation and filing inputs. Differences require compatible units and periods.
Explore enterprise value and market valuation multiples in the valuation sections.
Price framework
USD market cap plus reported borrowing debt, less cash and equivalents. This EV proxy excludes investments, preferred stock and noncontrolling-interest adjustments.
Complete market value, debt and cash evidence is required for enterprise value.
Complete market value, debt and cash evidence is required for enterprise value.
Price framework
The same filing-backed model used on each company's valuation page, with company-specific inputs and calculated scenarios.
STANLEY BLACK & DECKER, INC. · implied price per share
Reporting currency could not be verified.
BIO-TECHNE Corp · implied price per share
Reporting currency could not be verified.
Balance sheet health
Inspect reported liquidity and leverage alongside historical financial-health checks.
Financial strength on a 0–9 scale.
SWK · not enough data.
TECH · not enough data.
Bankruptcy-risk signal from balance sheet and earnings power.
Not enough data to score either balance sheet.
Cash excludes investments. EBITDA is an operating-income-plus-D&A proxy. Missing borrowing categories remain unavailable; select a value to inspect its inputs.
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
SMITH A O CORP
SWK vs AOS
WHIRLPOOL CORP /DE/
SWK vs WHR
NEWELL BRANDS INC.
SWK vs NWL
Snap-on Inc
SWK vs SNA
ILLINOIS TOOL WORKS INC
SWK vs ITW
THERMO FISHER SCIENTIFIC INC.
SWK vs TMO
DANAHER CORP /DE/
SWK vs DHR
AGILENT TECHNOLOGIES, INC.
SWK vs A
WATERS CORP /DE/
SWK vs WAT
ILLUMINA, INC.
SWK vs ILMN
BRUKER CORP
SWK vs BRKR
LLM-powered synthesis
An explanation of the financial evidence. Check its snapshot date against the figures above.
This explanation uses an earlier data snapshot or evidence version. Review its generation date and the current figures, or refresh after signing in.
If you believe SWK can reaccelerate growth while sustaining 14.4% operating margin and reducing 3.8x net debt/EBITDA, then hold or add; otherwise, the current price looks hard to justify because the DCF range is $38.54-$52.14 and TECH-implied upside is driven by TECH's much higher valuation multiples.
SWK trades at $94.58, which is above the top of the historical band ($104.04) only modestly but far above the DCF range ($38.54-$52.14) if cash-flow-based valuation is the anchor. TECH-implied price of $415.30 reflects TECH's elevated multiples and does not appear supported by SWK's lower growth and margin profile.
Supporting Metrics
